Addition of gabapentin to TPA formulary
Action 5375 / Stage 8818
Final Stage
| Status |
|
Changes to Text
|
No changes have been made to the text since the proposed stage was last published in the Register.
|
| Attorney General Review |
Submitted to OAG: 11/13/2019
Review Completed: 11/22/2019
Result: Certified
|
| Virginia Registrar |
Submitted on 11/22/2019
The Virginia Register of Regulations
Publication Date: 12/23/2019
Volume: 36 Issue: 9
|
|
Comment Period
|
No comment period held for this exempt action/stage.
|
|
Effective Date
|
1/22/2020
|
| Contact Information |
|
Name / Title:
|
Leslie L. Knachel
/
Executive Director
|
|
Address:
|
9960 Mayland Drive
Suite 300
Henrico, VA 23233
|
|
Email Address:
|
leslie.knachel@dhp.virginia.gov
|
|
Telephone:
|
(804)597-4130
FAX: (804)527-4471
TDD: ()-
|
This person is the primary contact for this board.
X
close window
Action 5375:
Addition of gabapentin to TPA formulary
Stages associated with this regulatory action.
| Stage Type |
Status |
|
Proposed
(8745)
|
Stage complete. Comment period ended 10/30/2019.
|
|
Final
(8818)
|
Stage complete. This regulation became effective on 01/22/2020.
|
X
close window
Place On Hold Pending External Action
Enter a reason up to 300 characters. Will be viewable only on the Governor's Pending List.
A stage can be placed "On Hold" only once. When there are major issues with a stage, please consider
asking the agency to withdraw the stage and submit a new stage when it is ready for review.
Final Text
Agency Background Document
